Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

1600021P15Rik Activators

1600021P15Rik activators comprise a diverse range of chemical compounds that exert their effects through various intracellular signaling pathways, leading to the enhancement of 1600021P15Rik's functional activity. Compounds like Forskolin and IBMX, by increasing intracellular cAMP levels, or PMA, which activates PKC, might indirectly enhance 1600021P15Rik if its functionality is linked to these signaling molecules. For instance, Forskolin stimulates adenylyl cyclase, thereby augmenting cAMP levels that can regulate proteins sensitive to cAMP-dependent phosphorylation, while IBMX prevents cAMP degradation, sustaining an environment conducive to the activation of cAMP-responsive proteins. PMA acts to activate PKC, which can phosphorylate a wide array of substrates and potentially enhance the activity of 1600021P15Rik through phosphorylation-dependent mechanisms. Similarly, the manipulation of intracellular calcium levels by Ionomycin and A23187 could trigger calcium-dependent signaling cascades that may upregulate 1600021P15Rik activity, assuming a role for calcium signaling in its regulation.

Furthermore, specific kinase inhibitors like LY294002, U0126, PD98059, and Epigallocatechin gallate (EGCG) may enhance 1600021P15Rik by modulating the activity of key signaling kinases and phosphatases that indirectly influence its state of activation. For example, LY294002 inhibits PI3K, potentially releasing 1600021P15Rik from PI3K/AKT pathway-mediated inhibition, while U0126 and PD98059 inhibit MEK, which might result in enhanced 1600021P15Rik activity by reducing competitive ERK signaling. EGCG's broad kinase inhibition could also relieve negative regulation on 1600021P15Rik, leading to its enhanced activity. Additionally, SB203580's inhibition of p38 MAPK may skew signaling towards pathways that favor the activation of 1600021P15Rik, and Okadaic Acid, by inhibiting protein phosphatases such as PP1 and PP2A, might increase the phosphorylation state of proteins within the cell, which could conceivably result in the activation of 1600021P15Rik if it is regulated by phosphorylation through these phosphatases. Collectively, these activators operate through intricate cellular networks to potentially amplify the activity of 1600021P15Rik without directly interacting with the protein, showcasing the complexity of intracellular signaling and its impact on protein function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX is a nonspecific inhibitor of phosphodiesterases, which prevents cAMP degradation, thus potentially sustaining an activated state that could enhance 1600021P15Rik activity if it is responsive to cAMP-mediated signaling.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC). If 1600021P15Rik is modulated by PKC signaling, PMA could indirectly enhance its activity by stimulating PKC-dependent phosphorylation events.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin functions as a calcium ionophore, raising intracellular calcium levels. If 1600021P15Rik is activated by calcium-signaling pathways, ionomycin can enhance its activity through this mechanism.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

BAPTA-AM is a cell-permeable calcium chelator that can regulate intracellular calcium levels. By modulating calcium signaling, it could indirectly enhance 1600021P15Rik if the protein is part of calcium-dependent pathways.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is known to inhibit several protein kinases. If 1600021P15Rik is regulated by kinase activity, EGCG could lead to an enhanced functional state by inhibiting competing kinases or pathways that negatively regulate 1600021P15Rik.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor. By inhibiting PI3K, it modulates the AKT signaling pathway. If 1600021P15Rik activity is downregulated by PI3K/AKT signaling, then LY294002 could enhance the protein's activity by alleviating this inhibition.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is another MEK inhibitor with similar potential effects as U0126. It could enhance 1600021P15Rik if the protein is regulated by the MAPK/ERK pathway and benefits from its inhibition.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor. If 1600021P15Rik is suppressed by p38 MAPK signaling, SB203580 could enhance the protein's activity by blocking this suppressive effect.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is a calcium ionophore like ionomycin and can raise intracellular calcium, potentially enhancing 1600021P15Rik through calcium-dependent signaling mechanisms.